Managing hyperthyroidism in cats with concurrent kidney disease is one of the most challenging clinical scenarios in feline medicine. Treatment decisions require careful assessment of competing welfare priorities.
Cats with concurrent hyperthyroidism and kidney disease face welfare risks from both conditions that must be carefully balanced in treatment planning. Treating hyperthyroidism without monitoring kidney function can precipitate kidney failure. Staged, carefully monitored treatment with quality of life as the primary outcome measure provides the best welfare approach for these complex cases.